Global Non-Invasive Cancer Diagnosis Market 2021: Top Industry Players, Growth Report to 2027

The global non-invasive cancer diagnosis market is anticipated to grow at a CAGR of 7.2% during the forecast period (2021-2027). The rising prevalence of cancer cases such as breast cancer, lung cancer, blood cancer, among others, increasing awareness for the treatment of cancer, and rising FDA approvals, are driving the non-invasive cancer diagnostics market during the forecast period. For instance, according to the US Breast Cancer Statistics, around 49,290 new cases of non-invasive breast cancer are estimated to diagnose in 2021. As per the American Cancer Society, around new cases of lung cancer 235,760 (119,100 in men and 116,660 in women), and deaths of around 131,880 due to lung cancer (69,410 in men and 62,470 in women) estimated in the US in 2021.

(Get 15% Discount on Buying this Report)

Get Report Sample Copy @ https://www.omrglobal.com/request-sample/non-invasive-cancer-diagnostics-market

Further, in December 2020, Hologic, Inc., a medical technology company that majorly focuses on improving women’s health, had announced that the U.S. Food and Drug Administration (FDA) approved the Genius AI Detection technology. The Genius AI Detection technology is a deep learning-based program that aids radiologists in detecting subtle possible cancers in tomosynthesis images of the breast. Besides, in May 2019, Novartis AG had announced that the US Food and Drug Administration, approved Piqray (alpelisib, formerly BYL719) in combination with fulvestrant for the treatment of postmenopausal women, and men, advanced or metastatic breast cancer. In September 2020, the Progranulin ELISA kit from A&G Pharmaceuticals Inc. was used to examine the relationship between progranulin serum level and disease status and survival in patients with metastatic breast cancer. However, the demand for the treatment of cancers, new drugs, and FDA approvals, and the increasing prevalence of cancer patients could impede the global non-invasive cancer diagnosis market over the coming years.

A Full Report of Global Non-Invasive Cancer Diagnosis Market is Available at: https://www.omrglobal.com/industry-reports/non-invasive-cancer-diagnostics-market

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Non-Invasive Cancer Diagnosis Market Report Segment

By Type

Blood Cancer
Solid Tumors
Breast Cancer
Lung Cancer
Others

By Techniques

Clinical Chemistry
Immunochemistry/Immunoassay
Molecular Diagnostics
Other Clinical Instruments

Global Non-Invasive Cancer Diagnosis Market Report Segment by Region

North America

US
Canada

Europe

Germany
United Kingdom
France
Spain
Italy
Rest of Europe

Asia-Pacific

China
Japan
India
Rest of Asia-Pacific

Rest of the World

Reasons to Buying From us –

1. We cover more than 15 major industries, further segmented into more than 90 sectors.

2. More than 120 countries are for analysis.

3. Over 100+ paid data sources mined for investigation.

4. Our expert research analysts answer all your questions before and after purchasing your report.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/non-invasive-cancer-diagnostics-market

Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404

About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.